iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Sees Strong Trading Volume – Should You Buy?

iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) saw unusually-strong trading volume on Thursday . Approximately 150,079 shares traded hands during mid-day trading, a decline of 2% from the previous session’s volume of 152,840 shares.The stock last traded at $104.85 and had previously closed at $105.93.

iShares U.S. Pharmaceuticals ETF Stock Down 0.8%

The firm has a market cap of $1.69 billion, a price-to-earnings ratio of 17.75 and a beta of 0.48. The business has a 50 day moving average of $101.21 and a 200 day moving average of $93.22.

Institutional Investors Weigh In On iShares U.S. Pharmaceuticals ETF

Several hedge funds have recently modified their holdings of the company. Foundations Investment Advisors LLC purchased a new stake in shares of iShares U.S. Pharmaceuticals ETF in the fourth quarter valued at $54,513,000. BNP Paribas Financial Markets purchased a new position in iShares U.S. Pharmaceuticals ETF during the second quarter worth about $13,108,000. Anfield Capital Management LLC acquired a new stake in iShares U.S. Pharmaceuticals ETF in the 4th quarter worth about $10,007,000. JPMorgan Chase & Co. boosted its stake in iShares U.S. Pharmaceuticals ETF by 89.4% in the 4th quarter. JPMorgan Chase & Co. now owns 212,805 shares of the company’s stock worth $18,052,000 after buying an additional 100,426 shares during the last quarter. Finally, Cetera Investment Advisers grew its holdings in iShares U.S. Pharmaceuticals ETF by 675.4% in the 1st quarter. Cetera Investment Advisers now owns 109,471 shares of the company’s stock valued at $9,489,000 after buying an additional 95,353 shares during the period.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.